February 17, 2026
Dana-Farber Cancer Institue

STAT+ | Breakup between Brigham and Dana-Farber is getting messier fast

Tensions between the two organizations had been simmering for years, and staff members are beginning to feel it in new ways.

By Jessica Bartlett — Boston Globe


STAT+ | FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher 

As part of the Commissioner's National Priority Review Voucher program, the agency had expedited review of the blood disorder therapy.

By Lizzy Lawrence and Adam Feuerstein


STAT+ | In a financial pinch, major health insurers are turning to AI for help

Insurance giants using AI to boost profits lead to other problems, including worry among providers about rising denials and lack of transparency.

By Casey Ross



Adobe

STAT+ | How pediatricians found themselves at war with RFK Jr.

American doctors are ignoring vaccine guidance from the U.S. government and making the AAP the most visible opposition to the MAHA vaccine agenda.

By Daniel Payne


More around STAT

In case you missed it

  • NM Senate committee advances bill to expand firefighter cancer coverage, Source NM
  • Suits against defunct Water Gremlin over cancer, chronic illness and wrongful death settled, CBS News
  • Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial, Reuters

Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.